chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness). At the time of the report, PAIN IN EXTREMITY (arm soreness) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Products known to have been used by the patient, within two weeks prior to the event, was not reported.  Treatment for the event  was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-054253 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054253:crosslink
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Neck pain, Pain in extremity
Clinical narrative: severe joint pain in my neck and shoulder; severe joint pain in my neck and shoulder; arm was sore; really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), HEADACHE (really bad headache), NECK PAIN (severe joint pain in my neck and shoulder) and ARTHRALGIA (severe joint pain in my neck and shoulder) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 immunisation.     No medical history reported.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and FINASTERIDE (PROSCAR) for an unknown indication.    On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was sore) and HEADACHE (really bad headache). On 18-Feb-2021, the patient experienced NECK PAIN (severe joint pain in my neck and shoulder) and ARTHRALGIA (severe joint pain in my neck and shoulder). The patient was treated with PARACETAMOL (TYLENOL) on 17-Feb-2021 for Headache, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm was sore), HEADACHE (really bad headache), NECK PAIN (severe joint pain in my neck and shoulder) and ARTHRALGIA (severe joint pain in my neck and shoulder) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Pruritus, Vaccination site pruritus
Clinical narrative: Whole upper arm was red with hives; Warm to touch but not itching; Sore for a few days; Arm more tender, very itchy and developing a rash; Rash, swelling and itching on the injection site; Rash, swelling and itching on the injection site; Rash, swelling and itching on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore for a few days), PRURITUS (Arm more tender, very itchy and developing a rash), VACCINATION SITE RASH (Rash, swelling and itching on the injection site), VACCINATION SITE SWELLING (Rash, swelling and itching on the injection site) and VACCINATION SITE PRURITUS (Rash, swelling and itching on the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore for a few days) and PRURITUS (Arm more tender, very itchy and developing a rash). 11-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash, swelling and itching on the injection site), VACCINATION SITE SWELLING (Rash, swelling and itching on the injection site) and VACCINATION SITE PRURITUS (Rash, swelling and itching on the injection site). On 19-Feb-2021, the patient experienced ERYTHEMA (Whole upper arm was red with hives) and FEELING HOT (Warm to touch but not itching). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site swelling, Vaccination site pruritus and Vaccination site rash, at an unspecified dose and frequency. On 14-Feb-2021, VACCINATION SITE SWELLING (Rash, swelling and itching on the injection site) and VACCINATION SITE PRURITUS (Rash, swelling and itching on the injection site) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore for a few days) had resolved, PRURITUS (Arm more tender, very itchy and developing a rash), ERYTHEMA (Whole upper arm was red with hives) and FEELING HOT (Warm to touch but not itching) outcome was unknown and VACCINATION SITE RASH (Rash, swelling and itching on the injection site) was resolving.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling
Clinical narrative: Whole upper arm was red with hives; Warm to touch but not itching; Sore for a few days; Arm more tender, very itchy and developing a rash; Rash, swelling and itching on the injection site; Rash, swelling and itching on the injection site; Rash, swelling and itching on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore for a few days), PRURITUS (Arm more tender, very itchy and developing a rash), VACCINATION SITE RASH (Rash, swelling and itching on the injection site), VACCINATION SITE SWELLING (Rash, swelling and itching on the injection site) and VACCINATION SITE PRURITUS (Rash, swelling and itching on the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore for a few days) and PRURITUS (Arm more tender, very itchy and developing a rash). 11-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash, swelling and itching on the injection site), VACCINATION SITE SWELLING (Rash, swelling and itching on the injection site) and VACCINATION SITE PRURITUS (Rash, swelling and itching on the injection site). On 19-Feb-2021, the patient experienced ERYTHEMA (Whole upper arm was red with hives) and FEELING HOT (Warm to touch but not itching). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site swelling, Vaccination site pruritus and Vaccination site rash, at an unspecified dose and frequency. On 14-Feb-2021, VACCINATION SITE SWELLING (Rash, swelling and itching on the injection site) and VACCINATION SITE PRURITUS (Rash, swelling and itching on the injection site) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore for a few days) had resolved, PRURITUS (Arm more tender, very itchy and developing a rash), ERYTHEMA (Whole upper arm was red with hives) and FEELING HOT (Warm to touch but not itching) outcome was unknown and VACCINATION SITE RASH (Rash, swelling and itching on the injection site) was resolving.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: No specific follow-up information recorded.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash, Vaccination site swelling
Clinical narrative: Tenderness at injection site; Redness at injection site; Swelling at injection site; Rash little down at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash little down at injection site), VACCINATION SITE PAIN (Tenderness at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L220A) for COVID-19 vaccination.     No medical history reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash little down at injection site). On an unknown date, the patient experienced VACCINATION SITE PAIN (Tenderness at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site). At the time of the report, VACCINATION SITE RASH (Rash little down at injection site), VACCINATION SITE PAIN (Tenderness at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  Treatment details included Tylenol (acetaminophen) and topical Benadryl (diphenhydramine).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Erythema, Fatigue
Clinical narrative: 4x4 red, hot, extremely itchy patch at the injection site; Itching; It looked red; Chills; Fever; Nausea; Extra fatigued; Diarrhea; Total weakness; Achiness; Soreness; Redness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ASTHENIA (Total weakness), PAIN (Achiness), VACCINATION SITE ERYTHEMA (Redness), CHILLS (Chills) and NAUSEA (Nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromyalgia, Arthritis, Arrhythmia, Hypertension and Anxiety. Concomitant products included CELECOXIB (CELEXA [CELECOXIB]) and ALPRAZOLAM (XANAX) for Anxiety, TRAMADOL for Arthritis, PARACETAMOL (TYLENOL) for Fibromyalgia, LISINOPRIL for Hypertension.  On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness). On 05-Feb-2021, the patient experienced ASTHENIA (Total weakness), PAIN (Achiness), CHILLS (Chills) and NAUSEA (Nausea). On 13-Feb-2021, the patient experienced PRURITUS (Itching) and ERYTHEMA (It looked red). On 06-Feb-2021, ASTHENIA (Total weakness), PAIN (Achiness), CHILLS (Chills) and NAUSEA (Nausea) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness) outcome was unknown and PRURITUS (Itching) and ERYTHEMA (It looked red) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information include Benadryl, Cortisone cream.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pruritus, Pyrexia, Vaccination site erythema
Clinical narrative: 4x4 red, hot, extremely itchy patch at the injection site; Itching; It looked red; Chills; Fever; Nausea; Extra fatigued; Diarrhea; Total weakness; Achiness; Soreness; Redness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ASTHENIA (Total weakness), PAIN (Achiness), VACCINATION SITE ERYTHEMA (Redness), CHILLS (Chills) and NAUSEA (Nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromyalgia, Arthritis, Arrhythmia, Hypertension and Anxiety. Concomitant products included CELECOXIB (CELEXA [CELECOXIB]) and ALPRAZOLAM (XANAX) for Anxiety, TRAMADOL for Arthritis, PARACETAMOL (TYLENOL) for Fibromyalgia, LISINOPRIL for Hypertension.  On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness). On 05-Feb-2021, the patient experienced ASTHENIA (Total weakness), PAIN (Achiness), CHILLS (Chills) and NAUSEA (Nausea). On 13-Feb-2021, the patient experienced PRURITUS (Itching) and ERYTHEMA (It looked red). On 06-Feb-2021, ASTHENIA (Total weakness), PAIN (Achiness), CHILLS (Chills) and NAUSEA (Nausea) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness) outcome was unknown and PRURITUS (Itching) and ERYTHEMA (It looked red) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information include Benadryl, Cortisone cream.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: 4x4 red, hot, extremely itchy patch at the injection site; Itching; It looked red; Chills; Fever; Nausea; Extra fatigued; Diarrhea; Total weakness; Achiness; Soreness; Redness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ASTHENIA (Total weakness), PAIN (Achiness), VACCINATION SITE ERYTHEMA (Redness), CHILLS (Chills) and NAUSEA (Nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromyalgia, Arthritis, Arrhythmia, Hypertension and Anxiety. Concomitant products included CELECOXIB (CELEXA [CELECOXIB]) and ALPRAZOLAM (XANAX) for Anxiety, TRAMADOL for Arthritis, PARACETAMOL (TYLENOL) for Fibromyalgia, LISINOPRIL for Hypertension.  On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness). On 05-Feb-2021, the patient experienced ASTHENIA (Total weakness), PAIN (Achiness), CHILLS (Chills) and NAUSEA (Nausea). On 13-Feb-2021, the patient experienced PRURITUS (Itching) and ERYTHEMA (It looked red). On 06-Feb-2021, ASTHENIA (Total weakness), PAIN (Achiness), CHILLS (Chills) and NAUSEA (Nausea) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness) outcome was unknown and PRURITUS (Itching) and ERYTHEMA (It looked red) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information include Benadryl, Cortisone cream.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Injection site pallor, Throat irritation
Clinical narrative: floaters the size of an eye on the injection site; throat was scratchy; soreness; Head ache; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PALLOR (floaters the size of an eye on the injection site), THROAT IRRITATION (throat was scratchy), INJECTION SITE PAIN (soreness) and HEADACHE (Head ache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included ANTIHYPERTENSIVES for Hypertension.   On 21-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced INJECTION SITE PALLOR (floaters the size of an eye on the injection site), THROAT IRRITATION (throat was scratchy), INJECTION SITE PAIN (soreness) and HEADACHE (Head ache). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Throat sore, at an unspecified dose and frequency. At the time of the report, INJECTION SITE PALLOR (floaters the size of an eye on the injection site), THROAT IRRITATION (throat was scratchy), INJECTION SITE PAIN (soreness) and HEADACHE (Head ache) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test positive
Clinical narrative: Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST POSITIVE (Tested positive for COVID-19) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No medical history reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced SARS-COV-2 ANTIBODY TEST POSITIVE (Tested positive for COVID-19). At the time of the report, SARS-COV-2 ANTIBODY TEST POSITIVE (Tested positive for COVID-19) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant drug information was not provided. Treatment was unknown.
Age: 33.0
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation
Clinical narrative: Burning and heat on foot; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of BURNING SENSATION (Burning and heat on foot) in a 33-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Burning and heat on foot). At the time of the report, BURNING SENSATION (Burning and heat on foot) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (little red splotchy spot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Medical history not reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (little red splotchy spot). At the time of the report, RASH MACULAR (little red splotchy spot) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.  No relevant concomitant medications were reported.  Treatment details included not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Pyrexia, Taste disorder
Clinical narrative: Fever; Headache; fatigue, feel tired; Redness at injection site; Warm to the touch at injection site; Food taste different for 2 days; Sore arm two day after injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm two day after injection), PYREXIA (Fever), HEADACHE (Headache), FATIGUE (fatigue, feel tired) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm two day after injection). On an unknown date, the patient experienced PYREXIA (Fever), HEADACHE (Headache), FATIGUE (fatigue, feel tired), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE WARMTH (Warm to the touch at injection site) and TASTE DISORDER (Food taste different for 2 days). At the time of the report, PAIN IN EXTREMITY (Sore arm two day after injection), PYREXIA (Fever), HEADACHE (Headache), FATIGUE (fatigue, feel tired), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE WARMTH (Warm to the touch at injection site) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Fever; Headache; fatigue, feel tired; Redness at injection site; Warm to the touch at injection site; Food taste different for 2 days; Sore arm two day after injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm two day after injection), PYREXIA (Fever), HEADACHE (Headache), FATIGUE (fatigue, feel tired) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm two day after injection). On an unknown date, the patient experienced PYREXIA (Fever), HEADACHE (Headache), FATIGUE (fatigue, feel tired), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE WARMTH (Warm to the touch at injection site) and TASTE DISORDER (Food taste different for 2 days). At the time of the report, PAIN IN EXTREMITY (Sore arm two day after injection), PYREXIA (Fever), HEADACHE (Headache), FATIGUE (fatigue, feel tired), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE WARMTH (Warm to the touch at injection site) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Headache, Nausea
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of chills, pyrexia (low-grade fever (99.7)), headache, nausea (nausea led to vomiting that lasted until 4 am) and vomiting (nausea led to vomiting that lasted until 4 am) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 041L20A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Jan 21, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 21, 2021, patient experienced chills, pyrexia (low-grade fever (99.7)), headache, nausea (nausea led to vomiting that lasted until 4 am), vomiting (nausea led to vomiting that lasted until 4 am) and diarrhea (little bit diarrhea). On Jan 24, 2021, patient experienced dizziness and tremor (shakiness). The patient was treated with ibuprofen for headache, at a dose of 200. On Jan 22, 2021, diarrhea (little bit diarrhea) resolved. On Jan 23, 2021, chills, pyrexia (low-grade fever (99.7)), headache, nausea (nausea led to vomiting that lasted until 4 am) and vomiting (nausea led to vomiting that lasted until 4 am) resolved. On Jan 24, 2021, dizziness and tremor (shakiness) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No relevant concomitant medications reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor, Vomiting
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of chills, pyrexia (low-grade fever (99.7)), headache, nausea (nausea led to vomiting that lasted until 4 am) and vomiting (nausea led to vomiting that lasted until 4 am) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 041L20A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Jan 21, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 21, 2021, patient experienced chills, pyrexia (low-grade fever (99.7)), headache, nausea (nausea led to vomiting that lasted until 4 am), vomiting (nausea led to vomiting that lasted until 4 am) and diarrhea (little bit diarrhea). On Jan 24, 2021, patient experienced dizziness and tremor (shakiness). The patient was treated with ibuprofen for headache, at a dose of 200. On Jan 22, 2021, diarrhea (little bit diarrhea) resolved. On Jan 23, 2021, chills, pyrexia (low-grade fever (99.7)), headache, nausea (nausea led to vomiting that lasted until 4 am) and vomiting (nausea led to vomiting that lasted until 4 am) resolved. On Jan 24, 2021, dizziness and tremor (shakiness) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No relevant concomitant medications reported.
Age: 88.0
Sex: U
Vaccine: COVID19
Symptoms: Pain, Skin burning sensation, Vaccination site movement impairment
Clinical narrative: Cant lift left arm; Burning sensation in upper arm/pain; pain; This spontaneous case was reported by a consumer and describes the occurrence of SKIN BURNING SENSATION (Burning sensation in upper arm/pain), PAIN (pain) and VACCINATION SITE MOVEMENT IMPAIRMENT (Cant lift left arm) in an 88-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     No medical history reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced SKIN BURNING SENSATION (Burning sensation in upper arm/pain) and PAIN (pain). On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Cant lift left arm). At the time of the report, SKIN BURNING SENSATION (Burning sensation in upper arm/pain), PAIN (pain) and VACCINATION SITE MOVEMENT IMPAIRMENT (Cant lift left arm) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.  No relevant concomitant medications were reported.  No treatment information was provided.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: mild soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (mild soreness at the injection site) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified, Arthritis and Drug allergy. Concomitant products included POTASSIUM, VITAMINS NOS, VITAMIN D NOS, POLYCARBOPHIL CALCIUM (FIBER) and PARACETAMOL (TYLENOL) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 01-Feb-2021, the patient experienced VACCINATION SITE PAIN (mild soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (mild soreness at the injection site) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications included unknown heart medications, unknown water pill and fiber.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site erythema, Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: bumpy at injection site; Itchy at injection site; Looks like a rash; Red at injection site; A spontaneous report was received from a Consumer concerning a 69 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced redness at injection site, itchy at injection site, bumpy at injection site and looks like a rash.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 19 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot batch: 0321L20A) intramuscularly in left arm for prophylaxis of COVID-19 infection.  On 19 Jan 2021, the patient experienced redness at injection site, itchy at injection site, bumpy at injection site and looks like a rash.  No treatment taken.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm soreness) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm soreness). At the time of the report, VACCINATION SITE PAIN (Arm soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment medications were not reported. The patient reported that the symptoms lasted 2 to 3 days.   This case was linked to MOD-2021-018176 (Patient Link).
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Headache, Vaccination site movement impairment, Vaccination site pain, Vaccination site swelling
Clinical narrative: after some hours her breast started to hurt (same side of vaccination); she can't raise arm; arm swelling; the arm is very painful; headache; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (after some hours her breast started to hurt (same side of vaccination)), VACCINATION SITE MOVEMENT IMPAIRMENT (she can't raise arm), VACCINATION SITE SWELLING (arm swelling), VACCINATION SITE PAIN (the arm is very painful) and HEADACHE (headache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022H20A) for COVID-19 vaccination.     Concomitant products included NABUMETONE (RELAFEN) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced BREAST PAIN (after some hours her breast started to hurt (same side of vaccination)), VACCINATION SITE MOVEMENT IMPAIRMENT (she can't raise arm), VACCINATION SITE SWELLING (arm swelling), VACCINATION SITE PAIN (the arm is very painful) and HEADACHE (headache). At the time of the report, BREAST PAIN (after some hours her breast started to hurt (same side of vaccination)), VACCINATION SITE MOVEMENT IMPAIRMENT (she can't raise arm), VACCINATION SITE SWELLING (arm swelling), VACCINATION SITE PAIN (the arm is very painful) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that the second dose was scheduled for 03-Mar-2021.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Severe reaction to steroids injections; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ADVERSE REACTION (Severe reaction to steroids injections) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 039k20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder. Concomitant products included LEVOTHYROXINE for Thyroid disorder, LOSARTAN for an unknown indication.   On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced ADVERSE REACTION (Severe reaction to steroids injections). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 02-Feb-2021, ADVERSE REACTION (Severe reaction to steroids injections) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication reported included another pills for thyroid.  On 02 Feb 2021 the patient put two steroids injections, half an hour later she had a severe reaction to both injections. It was pretty severe reaction. Her doctor told her it was extremely weird to have a reaction to steroids. She think probably if related the covid-19 vaccine that maybe attack her immune system and produce this reaction.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: redness (around injection site); bumpiness (at injection site); hot to the touch (at injection site); rash (at injection site); itchy all around injection site, 2-3inches in width; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at injection site), VACCINATION SITE ERYTHEMA (redness (around injection site)), VACCINATION SITE MASS (bumpiness (at injection site)), VACCINATION SITE WARMTH (hot to the touch (at injection site)) and VACCINATION SITE RASH (rash (at injection site)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site). On 31-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness (around injection site)), VACCINATION SITE MASS (bumpiness (at injection site)), VACCINATION SITE WARMTH (hot to the touch (at injection site)), VACCINATION SITE RASH (rash (at injection site)) and VACCINATION SITE PRURITUS (itchy all around injection site, 2-3inches in width). At the time of the report, VACCINATION SITE PAIN (soreness at injection site), VACCINATION SITE ERYTHEMA (redness (around injection site)), VACCINATION SITE MASS (bumpiness (at injection site)), VACCINATION SITE WARMTH (hot to the touch (at injection site)), VACCINATION SITE RASH (rash (at injection site)) and VACCINATION SITE PRURITUS (itchy all around injection site, 2-3inches in width) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication was not reported.  The treatment medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: redness (around injection site); bumpiness (at injection site); hot to the touch (at injection site); rash (at injection site); itchy all around injection site, 2-3inches in width; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at injection site), VACCINATION SITE ERYTHEMA (redness (around injection site)), VACCINATION SITE MASS (bumpiness (at injection site)), VACCINATION SITE WARMTH (hot to the touch (at injection site)) and VACCINATION SITE RASH (rash (at injection site)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site). On 31-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness (around injection site)), VACCINATION SITE MASS (bumpiness (at injection site)), VACCINATION SITE WARMTH (hot to the touch (at injection site)), VACCINATION SITE RASH (rash (at injection site)) and VACCINATION SITE PRURITUS (itchy all around injection site, 2-3inches in width). At the time of the report, VACCINATION SITE PAIN (soreness at injection site), VACCINATION SITE ERYTHEMA (redness (around injection site)), VACCINATION SITE MASS (bumpiness (at injection site)), VACCINATION SITE WARMTH (hot to the touch (at injection site)), VACCINATION SITE RASH (rash (at injection site)) and VACCINATION SITE PRURITUS (itchy all around injection site, 2-3inches in width) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication was not reported.  The treatment medication was not reported.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Vaccination site pain
Clinical narrative: toes on both feet are swollen; toes on both feet are red; toes on both feet are tender to the touch; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (toes on both feet are swollen), ERYTHEMA (toes on both feet are red), PAIN IN EXTREMITY (toes on both feet are tender to the touch) and VACCINATION SITE PAIN (sore arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 31-Jan-2021, the patient experienced PERIPHERAL SWELLING (toes on both feet are swollen), ERYTHEMA (toes on both feet are red) and PAIN IN EXTREMITY (toes on both feet are tender to the touch). On 30-Jan-2021, VACCINATION SITE PAIN (sore arm) had resolved. At the time of the report, PERIPHERAL SWELLING (toes on both feet are swollen), ERYTHEMA (toes on both feet are red) and PAIN IN EXTREMITY (toes on both feet are tender to the touch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not reported. Treatment medication were not reported. The patient had sore arm for a day the day after.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Gait disturbance, Oxygen saturation, Oxygen saturation decreased
Clinical narrative: Hard time walking; O2 levels decreased to 88%; He's had covid symptoms before but these are worse this time; He's having a harder time breathing; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Hard time walking), OXYGEN SATURATION DECREASED (O2 levels decreased to 88%), COVID-19 (He's had covid symptoms before but these are worse this time) and DYSPNOEA (He's having a harder time breathing) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L2OA) for COVID-19 vaccination.     Concurrent medical conditions included COVID-19.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (Hard time walking), OXYGEN SATURATION DECREASED (O2 levels decreased to 88%), COVID-19 (He's had covid symptoms before but these are worse this time) and DYSPNOEA (He's having a harder time breathing). The patient was treated with OXYGEN for Oxygen saturation decreased, at a dose of level 1 to level 3. At the time of the report, GAIT DISTURBANCE (Hard time walking), COVID-19 (He's had covid symptoms before but these are worse this time) and DYSPNOEA (He's having a harder time breathing) had not resolved and OXYGEN SATURATION DECREASED (O2 levels decreased to 88%) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Oxygen saturation: 88 % (Low) decreased to 88%.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Oxygen was increased from usual level 1 to level 3.  It was reported that the patient was using walker at the time of report because he had a harder time walking. The patient had to use walker 2 days after the injection.  Patient was due for 2nd shot in the next 2 weeks to the day of report. The patient also had a follow-up visit 3 days prior to the report with his HCP and did not know what to do. The patient was told to take Aleve but denied taking it.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache
Clinical narrative: Chills; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and HEADACHE (Slight headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced CHILLS (Chills) and HEADACHE (Slight headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, CHILLS (Chills) and HEADACHE (Slight headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Body temperature: 98 (Inconclusive) t°98 something.         Concomitant medication not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Feeling abnormal, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt bad), COVID-19 (tested positive for Covid-19), PYREXIA (fever) and MYALGIA (body aches) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced FEELING ABNORMAL (Felt bad), PYREXIA (fever) and MYALGIA (body aches). On an unknown date, the patient experienced COVID-19 (tested positive for Covid-19). The patient was treated with PARACETAMOL (TYLENOL) for Feels bad, COVID-19, Fever and Myalgia, at a dose of UNK dosage form. At the time of the report, FEELING ABNORMAL (Felt bad), COVID-19 (tested positive for Covid-19), PYREXIA (fever) and MYALGIA (body aches) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. On 04-Feb-2021 patient was feeling better (isolation ends next day of report).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia, Vaccination complication
Clinical narrative: feeling crappy; low grade fever; body ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (feeling crappy), PYREXIA (low grade fever), MYALGIA (body ache) and HEADACHE (headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Feeling unwell on 03-Feb-2021. Concomitant products included PARACETAMOL (TYLENOL) from 03-Feb-2021 to an unknown date for Feeling unwell.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION COMPLICATION (feeling crappy), PYREXIA (low grade fever), MYALGIA (body ache) and HEADACHE (headache). At the time of the report, VACCINATION COMPLICATION (feeling crappy), PYREXIA (low grade fever), MYALGIA (body ache) and HEADACHE (headache) outcome was unknown. Not Provided          The patient did not take anything to treat her symptoms.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Energy increased, Middle insomnia, Restlessness, Tremor, Vaccination complication
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RESTLESSNESS (She just could not relax), ENERGY INCREASED (She had so much energy), VACCINATION COMPLICATION (She felt so weird), TREMOR (She was shaking) and MIDDLE INSOMNIA (woke up suddenly from her sleep) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced RESTLESSNESS (She just could not relax), ENERGY INCREASED (She had so much energy), VACCINATION COMPLICATION (She felt so weird), TREMOR (She was shaking) and MIDDLE INSOMNIA (woke up suddenly from her sleep). On 01-Feb-2021, RESTLESSNESS (She just could not relax), ENERGY INCREASED (She had so much energy), VACCINATION COMPLICATION (She felt so weird), TREMOR (She was shaking) and MIDDLE INSOMNIA (woke up suddenly from her sleep) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  About 8-9 hours after receiving the vaccine she started experiencing some side effects. It was like a shock to her immune system. The symptoms subsided after about 1 hour and 30 minutes. The patient had been fine since that one episode. The patient did not take anything to alleviate the symptoms. The patient had not reached out to her healthcare provider.